ArticleJournal of pharmacy & bioallied sciences2025
Association of Preoperative Controlling Nutritional Status (CONUT) Score with the Staging of Cervical Cancer.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early-stage cervical cancer is commonly managed with radical hysterectomy, followed by "concurrent chemoradiotherapy (CCRT)" in subjects with high-risk pathological features. Nutritional and immune status, as measured by the "Controlling Nutritional Status (CONUT)" score, may predict these adverse outcomes preoperatively. Objective: To evaluate the association between preoperative CONUT scores and pathological risk factors for tumor recurrence in early-stage cervical cancer. Methods: A cross-sectional analytical research was conducted on 116 subjects with International Federation of Gynecology and Obstetrics stages IA-IIA cervical cancer at a tertiary center in Bangladesh. CONUT scores were calculated based on serum albumin, cholesterol, and lymphocyte count. Associations were examined between CONUT score and recurrence-related factors, including "lymphovascular space invasion (LVSI)," lymph node metastasis, parametrial invasion, and positive resection margin. Results: High CONUT scores (≥3) were found in 44.8% of patients. These subjects showed significantly higher rates of LVSI (7.7% vs. 1.6%) and lymph node metastasis (11.5% vs. 3.1%). Overall, high CONUT scores were significantly associated with increased likelihood of at least one recurrence risk factor ( Conclusion: High preoperative CONUT scores are predictive of adverse pathological features in early-stage cervical cancer and may aid in risk stratification and personalized treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.